Skip to content

Clinical trials

Completed Phase 2 Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 2 Status: Completed Clear all

225 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20026
20034
200416
200513
20068
200720
200813
20098
201012
20119
201216
20135
201412
20157
20169
20178
20188
20194
20201
20218
20225
20233
20243
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed225

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals13
National Heart, Lung, and Blood Institute (NHLBI)12
Novartis6
Alcon Research5
Boehringer Ingelheim4
Ionis Pharmaceuticals, Inc.4
Takeda4
University of Texas Southwestern Medical Center4
Alnylam Pharmaceuticals3
Boryung Pharmaceutical Co., Ltd3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension225
Cardiovascular Diseases22
Diabetes Mellitus15
Diabetes Mellitus, Type 214
Obesity14
Heart Diseases13
Metabolic Syndrome11
Essential Hypertension10
Vascular Diseases10
Diabetic Nephropathies7

Trials

Showing 1 to 25 of 225. Each trial links to its page on Pharma Observatory.

125 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.